The myeloid switch: immune drivers in atopic dermatitis — roles in pathogenesis and emerging therapeutic targeting
Authors:
Open Access
- 30 June 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1608338
Abstract
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases worldwide, significantly impairing patients’ quality of life. It is characterized by recurrent eczematous lesions, intense pruritus, and disruption of the epidermal barrier. The pathogenesis of AD is multifactorial and involves complex interactions between genetic predisposition, environmental triggers, skin barrier defects, microbial dysbiosis, and immune dysregulation. While much of the research in recent decades has focused on the type 2 helper T cell (Th2)-driven adaptive immune responses that dominate the acute phase of the disease, the role of innate immunity—particularly that of myeloid cells—has emerged as a crucial and underrated component in disease pathogenesis and progression. This review highlights recent findings on the role of myeloid cells in the initiation, maintenance, and amplification of inflammation in AD. Myeloid cells respond to a wide range of environmental and tissue-derived triggers, including cytokines, alarmins, and microbial products. Upon activation, they contribute to the inflammatory milieu by producing chemokines and cytokines, presenting antigens, and recruiting other immune cells to the skin. Importantly, myeloid cells not only shape the local immune landscape but also engage in crosstalk with keratinocytes and adaptive immune cells, thereby reinforcing chronic inflammation. In addition, the review outlines emerging therapeutic strategies aimed at modulating myeloid cell function or selectively targeting pro-inflammatory subsets. These approaches offer promising avenues that complement existing Th2-centered therapies, addressing disease mechanisms beyond the adaptive immune response. A deeper understanding of the diverse and dynamic roles of myeloid cells in AD may thus support the development of more comprehensive and personalized treatment strategies for long-term disease control.Keywords
This publication has 141 references indexed in Scilit:
- SIRT1-Mediated HMGB1 Deacetylation Suppresses Neutrophil Extracellular Traps Related to Blood–Brain Barrier Impairment After Cerebral Venous ThrombosisMolecular Neurobiology, 2024
- Regulatory Role of Nitric Oxide in Cutaneous InflammationInflammation, 2022
- Toll like-receptor agonist Pam3Cys modulates the immunogenicity of liposomes containing the tuberculosis vaccine candidate H56Medical Microbiology and Immunology, 2020
- Adoptive transfer of IFN-γ-induced M-MDSCs promotes immune tolerance to allografts through iNOS pathwayInflammation Research, 2019
- Role of Dendritic Cells in Atopic Dermatitis: An UpdateClinical Reviews in Allergy & Immunology, 2010
- Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical studyArchives of Dermatological Research, 2006
- Neutrophil recruitment in mast cell-dependent inflammation: inhibitory mechanisms of glucocorticoidsInflammation Research, 2004
- Mannose receptor‐mediated uptake of antigens strongly enhances HLA class II‐restricted antigen presentation by cultured dendritic cellsEuropean Journal of Immunology, 1997
- Th1-Zellen, Th2-Zellen und atopische DermatitisDie Dermatologie, 1997
- Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitisArchives of Dermatological Research, 1997